Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	date of answer exactly: or between: and answering member constituency
creator	label
publisher	pref label
tabling member	label

Search

947011

	human indexable
	published
	registered interest
	answer date	04/09/2018
	date	23/07/2018
	date tabled	23/07/2018
	ddp created	23/07/2018 22:00:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2018 22:19:17 04/09/2018 16:32:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	167294
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	04/09/2018 16:00:47
	question text	To ask the Secretary of State for Health and Social Care, whether he has undertaken an impact assessment on the potential beneficial effects of regulating the dispensing of special medicinal products in England.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 167294
	type	WrittenParliamentaryQuestion
	uin	167294
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 04/09/2018 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047025

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:04:39
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:15:02 28/01/2019 17:52:01
	hansard heading	NHS: Drugs
	house id	1
	identifier	211794
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:20:24
	question text	To ask the Secretary of State for Health and Social Care, how many times he has used his powers under the Health Service Medical Supplies (Costs) Act 2017 to impose lower prices on unbranded generic or off-patent medicines sold to the NHS; and how many companies have had lowered prices as a result of those powers.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211794
	type	WrittenParliamentaryQuestion
	uin	211794
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110241

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:25:20
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/04/2019 23:55:37 11/04/2019 17:32:10
	hansard heading	NHS: Drugs
	house id	1
	identifier	242154
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:57:37
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Scottish Government’s Chief Pharmaceutical Officer on the implementation of legislative changes in the Human Medicines (Amendment) Regulations 2019 (S.I., 2019, No. 62).
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242154
	type	WrittenParliamentaryQuestion
	uin	242154
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/04/2019 answering member constituency South Ribble
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047027

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:04:43
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:15:06 28/01/2019 17:53:08
	hansard heading	NHS: Drugs
	house id	1
	identifier	211795
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:21:03
	question text	To ask the Secretary of State for Health and Social Care, whether the NHS' spend on unbranded generic or off-patent medicines has reduced since the Health Service Medical Supplies (Costs) Act 2017 came into force.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211795
	type	WrittenParliamentaryQuestion
	uin	211795
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110245

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:25:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/04/2019 23:55:49 11/04/2019 16:45:13
	hansard heading	NHS: Drugs
	house id	1
	identifier	242155
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:09:07
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Scotland’s Cabinet Secretary for Health and Sport on the stockpiling of drugs in preparation for the UK’s departure from the EU.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242155
	type	WrittenParliamentaryQuestion
	uin	242155
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/04/2019 answering member constituency Wimbledon
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110280

	human indexable
	published
	registered interest
	answer date	10/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:43:07
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/04/2019 00:01:06 11/04/2019 16:45:12
	hansard heading	NHS: Drugs
	house id	1
	identifier	242156
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:09:07
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with Scotland’s Cabinet Secretary for Health and Sport on what processes will be in place to add a drug to the list of those deemed to be in short supply following the UK’s departure from the EU.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242156
	type	WrittenParliamentaryQuestion
	uin	242156
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 11/04/2019 answering member constituency Wimbledon
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1047114

	human indexable
	published
	registered interest
	answer date	28/01/2019
	date	23/01/2019
	date tabled	23/01/2019
	ddp created	23/01/2019 19:09:20
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2019 19:28:04 28/01/2019 17:54:05
	hansard heading	NHS: Drugs
	house id	1
	identifier	211797
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	28/01/2019 17:22:39
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an (a) assessment of the equity of the level of remuneration for special medicinal products sold to the NHS and (b) estimate of what is an equitable amount of remuneration; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 211797
	type	WrittenParliamentaryQuestion
	uin	211797
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 28/01/2019 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

947297

	human indexable
	published
	registered interest
	answer date	05/09/2018
	date	24/07/2018
	date tabled	24/07/2018
	ddp created	24/07/2018 18:49:24
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/07/2018 18:59:45 05/09/2018 10:57:02
	hansard heading	NHS: Drugs
	house id	1
	identifier	167951
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/09/2018 10:25:43
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the NHS in England of special medicinal products over the last 12 months.
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 167951
	type	WrittenParliamentaryQuestion
	uin	167951
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 05/09/2018 answering member constituency Winchester
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford

1110235

	human indexable
	published
	registered interest
	answer date	11/04/2019
	date	08/04/2019
	date tabled	08/04/2019
	ddp created	08/04/2019 23:16:52
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/04/2019 23:43:48 11/04/2019 17:32:04
	hansard heading	NHS: Drugs
	house id	1
	identifier	242153
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	11/04/2019 16:59:00
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with community (a) pharmacies and (b) pharmacy organisations in Scotland on the implementation of the Human Medicines (Amendment) Regulations 2019 (S.I., 2019, No. 62).
	session	2017/19
	session number	1
	tabling member constituency	Central Ayrshire
	tabling member printed	Dr Philippa Whitford
	title	House of Commons Tabled Parliamentary Question 2017/19 242153
	type	WrittenParliamentaryQuestion
	uin	242153
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 11/04/2019 answering member constituency South Ribble
	creator	4385 label Biography information for Dr Philippa Whitford
	publisher	25259 pref label House of Commons
	tabling member	4385 label Biography information for Dr Philippa Whitford